Center on Intersystem Regulation by Drugs of Abuse

$1,410,054P30FY2018DANIH

Temple Univ Of The Commonwealth, Philadelphia PA

Investigators

Linked publications & trials

Paper 39702361 Paper 39620471 Paper 39518941 Paper 39517684 Paper 39433903 Paper 39300273 Paper 39053627 Paper 38854027 Paper 38534474 Paper 38514040 Paper 38409113 Paper 38293836 Paper 38199516 Paper 38116176 Paper 38076811 Paper 38036039 Paper 37625214 Paper 37573960 Paper 37508844 Paper 37392779 Paper 37376759 Paper 36871847 Paper 36815027 Paper 36534642 Paper 36521236 Paper 36408401 Paper 36238569 Paper 36174884 Paper 36139385 Paper 36093282 Paper 36017612 Paper 35905805 Paper 35843139 Paper 35792570 Paper 35779192 Paper 35652052 Paper 35529434 Paper 35514978 Paper 35320877 Paper 35216375 Paper 35163373 Paper 35051699 Paper 34979130 Paper 34871976 Paper 34736959 Paper 34576988 Paper 34531761 Paper 34500853 Paper 34435263 Paper 34290298 Paper 34244232 Paper 34146575 Paper 34085120 Paper 33940234 Paper 33834276 Paper 33826336 Paper 33758061 Paper 33754230 Paper 33689166 Paper 33648543 Paper 33631465 Paper 33593913 Paper 33590767 Paper 33580386 Paper 33465606 Paper 33404775 Paper 33380174 Paper 33291057 Paper 33231727 Paper 33042154 Paper 32976891 Paper 32897695 Paper 32814790 Paper 32585256 Paper 32517185 Paper 32454064 Paper 32243899 Paper 32145665 Paper 32076421 Paper 31908004 Paper 31867624 Paper 31783102 Paper 31756109 Paper 31734036 Paper 31682867 Paper 31568781 Paper 31557508 Paper 31420527 Paper 31361029 Paper 31347447 Paper 31313616 Paper 31302200 Paper 31279825 Paper 31275220 Paper 31236436 Paper 31218677 Paper 31029877 Paper 30980094 Paper 30951749 Paper 30905008

Abstract

DESCRIPTION (provided by applicant): This application is for the renewal of the NIDA P30 Center on Intersystem Regulation by Drugs of Abuse at Temple University. The Center has been successful in catalyzing interdisciplinary research, enhancing productivity, and creating synergy. The Core facilities have enabled individual researchers to extend their funded projects, brought new researchers into the field of substance abuse, and created a scientifically exciting atmosphere that resulted in successful recruitment of new faculty. This renewal application requests support for five Research Support Cores: Animal Models and Behavioral Testing, Biochemical Pharmacology, Cell and Immunology, Integrative Pharmacology, and Molecular Biology Cores, as well as Pilot Project Core and the Administrative Core. Changes in this renewal application include restructuring the Cores, addition of new key investigators who bring added expertise, and additional state-of-the-art innovative technologies, all of which will add major strengths to the Center. The NIDA P30 Core Center will support primarily preclinical research on drugs of abuse and addiction, with translational applications. Major integrative themes of the Center are 1) mechanisms of addiction and identification of novel therapeutic targets; 2) effects of drugs of abuse on HIV infection and other endpoints such as pain and behavior; 3) neuroimmune interactions, including cross-talk between opioids, cannabinoids and chemokines as related to pain, inflammation, and HIV; and 4) analysis of drug combinations. The Cores and their investigators have the ability to attack research problems from multiple levels, with expertise in molecular, cellular, immunological, pharmacological and behavioral approaches. This unique aspect of the Center encourages multi-disciplinary collaborations to best address novel hypotheses and significantly advance individual research programs. The NIDA P30 Core Center will provide cutting-edge technologies to the 25 NIH-funded research projects identified in the proposal as related to NIDA's mission, as well as our NIDA-supported trainees. The Center has, and will continue to, enhance synergy and productivity, and to stimulate innovative scientific discoveries that will result in new knowledge to bear on substance abuse.

View original record on NIH RePORTER →